Mutations of extracellular matrix components in vascular disease
- PMID: 10391325
- DOI: 10.1016/s0003-4975(99)00437-3
Mutations of extracellular matrix components in vascular disease
Abstract
Background: Marfan's syndrome (MFS) is characterized by manifestations in the skeletal, ocular, and cardiovascular systems. Dilatation of the aortic root is the hallmark feature in the cardiovascular system. Aortic dilatation is associated with fragmented elastic fibers and accumulation of amorphous matrix elements in the medial layer. This pathology is caused by mutations in fibrillin 1, the major structural component of elastic microfibrils. Fibrillin 1 mutations may affect the assembly or function of the elastic microfibrils or both. To answer this important question, MFS-like mice have been created.
Methods: MFS-like mice were generated by homologous gene targeting in embryonic stem cells. Targeting of the mouse fibrillin 1 gene had the dual effect of reducing gene expression 10-fold and of producing an internally deleted protein.
Results: Mutant homozygous mice make very small amounts of only mutant fibrillin 1 and die postnatally of MFS-like vascular complications. Histopathological findings include focal fragmentation of elastic fibers and accumulation of amorphous matrix in the aortic media.
Conclusions: A mouse model for the severe form of MFS has been created using the technique of gene targeting. Aside from its clinical value, the model has demonstrated that fibrillin 1 is predominantly involved in the function rather than the assembly of elastic microfibrils.
Similar articles
-
Marfan syndrome: new clues to genotype-phenotype correlations.Ann Med. 1999 Jun;31(3):202-7. doi: 10.3109/07853899909115979. Ann Med. 1999. PMID: 10442675 Review.
-
Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome.Nat Genet. 1997 Oct;17(2):218-22. doi: 10.1038/ng1097-218. Nat Genet. 1997. PMID: 9326947
-
Genetic fibrillinopathies: new insights in molecular diagnosis and clinical management.Acta Clin Belg. 2003 Jan-Feb;58(1):3-11. doi: 10.1179/acb.2003.58.1.001. Acta Clin Belg. 2003. PMID: 12723256 Review.
-
Elastic and collagenous networks in vascular diseases.Cell Struct Funct. 2000 Apr;25(2):69-72. doi: 10.1247/csf.25.69. Cell Struct Funct. 2000. PMID: 10885576 Free PMC article. Review.
-
[Molecular mechanisms for the improvement of wound healing ability of periodontal ligament in Marfan's syndrome].Clin Calcium. 2012 Jan;22(1):35-42. Clin Calcium. 2012. PMID: 22201097 Review. Japanese.
Cited by
-
New fibrillin gene mutation - possible cause of ascending aortic dilation in patients with aortic valve disease: Preliminary results.Int J Angiol. 2009 Summer;18(2):99-102. doi: 10.1055/s-0031-1278335. Int J Angiol. 2009. PMID: 22477503 Free PMC article.
-
Aortic Involvement in Pediatric Marfan syndrome: A Review.Pediatr Cardiol. 2015 Jun;36(5):887-95. doi: 10.1007/s00246-015-1101-0. Epub 2015 Feb 11. Pediatr Cardiol. 2015. PMID: 25669767 Review.
-
Large animal models of cardiovascular disease.Cell Biochem Funct. 2016 Apr;34(3):113-32. doi: 10.1002/cbf.3173. Epub 2016 Feb 24. Cell Biochem Funct. 2016. PMID: 26914991 Free PMC article. Review.
-
A multi-layered computational model of coupled elastin degradation, vasoactive dysfunction, and collagenous stiffening in aortic aging.Ann Biomed Eng. 2011 Jul;39(7):2027-45. doi: 10.1007/s10439-011-0287-4. Epub 2011 Mar 5. Ann Biomed Eng. 2011. PMID: 21380570 Free PMC article.
-
Two Novel Pathogenic FBN1 Variations and Their Phenotypic Relationship of Marfan Syndrome.Glob Med Genet. 2020 Aug;7(2):68-71. doi: 10.1055/s-0040-1714092. Epub 2020 Aug 20. Glob Med Genet. 2020. PMID: 32939518 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical